Restricted accessResearch articleFirst published online 2011-08
Antiproliferative Activity and Cell Cycle Analysis of 2-(3,5-Dihydroxyphenyl)-6-Hydroxybenzothiazole on MCF-7 Breast and HCT-15 Colon Cancer Cell Lines
The antiproliferative activity of 2-(3,5-Dihydroxyphenyl)-6-hydroxybenzothiazole (DHB) is reported here. DHB inhibits the growth of human colon cancer HCT-15 with a 50% cell growth inhibition value of 23 μM and breast cancer MCF-7 with a 50% cell growth inhibition value of 41 μM in a dose/time dependent manner by using sulforhodamine B assay. Cell cycle analysis by flow cytometry showed that DHB-induced growth arrest could be associated with apoptosis in both cell lines. Moreover, suppression of clonogenic activity occurs after exposure to DHB at a concentration of 25 μM for HCT-15 and of 40 μM for MCF-7.
Get full access to this article
View all access options for this article.
References
1.
AkbayA., OrenI., Temiz-ArpaciO., Aki-SenerE., YalcinI.2003. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo (4,5-b) pyridine derivatives. Arzneimittelforschung, 53:266–271.
2.
BanM., TaguchiH., KatsushimaT., TakahashiM., ShinodaK., WatanabeA., TominagaT.1998. Novel antiallergic and anti-inflammatory agents. Part I: synthesis and pharmacology of glycolic amide derivatives. Bioorg Med Chem, 6:1069–1076.
3.
BertiniS., CalderoneV., CarboniI., MaffeiR., MartelliA., MartinelliA., MinutoloF., RajabiM., TestaiL., TuccinardiT., GhidoniR., MacchiaM.2010. Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties. Bioorg Med Chem, 18:6715–6724.
4.
BradshawT.D., StevensM.F., WestwellA.D.2001. The discovery of the potent and selective antitumor agent 2-(4-amino-3-methylphenyl)benzothiazoles (DF 203) and related compounds. Curr Med Chem, 8:203–210.
5.
BradshawT.D., WestwellA.D.2004. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr Med Chem, 11:1009–1021.
6.
CaoY.J., DreixlerJ.C., CoueyJ.J., HouamedK.M.2002. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur J Pharmacol, 449:47–54.
7.
DasJ., MoquinR.V., LinC.J., LiuJ., DoweykoA.M., DefexH.F., FangQ., PangS.H., PittS., ShenD.R., SchievenG.L., BarrishJ.C., WityakJ.2003. Discovery of 2-amino-heteroarylbenzothiazole-6-anilides as potent p56(lck) inhibitors. Bioorg Med Chem Lett, 13:2587–2590.
8.
HallI.H., PeatyN.J., HenryJ.R., EasmonJ., HeinischG., PurstingerG.1999. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine. Arch Pharm, 332:115–123.
9.
JungM.H., ChoiS.W., ParkJ.G., ChoK.W., KongJ.Y.1999. Studies of muscarinic receptor agonists: 2-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl) benzoxazoles/benzothiazole. Korean J Med Chem, 9:56–62.
10.
KarabatsosG.J., HsiN.1967. Structural studies by nuclear magnetic resonance—XI: conformations and configurations of oxime o-methyl ethers. Tetrahedron, 23:1079–1095.
11.
MehrzadJ., RajabiM., KhalilzadehM.A.2010. Design and antiproliferative activity of 2-(3,5-Dihydroxyphenyl)-6-hydroxybenzothiazole (DHB) on PC-3 prostate cancer cell line. Iran J Org Chem, 2:498–500.
12.
MinutoloF., SalaG., BagnacaniA., BertiniS., CarboniI., PlacanicaG., ProtaG., RapposelliS., SacchiN., MacchiaM., GhidoniR.2005. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. J Med Chem, 48:6783–6786.
13.
NafisiS., HashemiM., RajabiM., Tajmir-RiahiH.A.2008. DNA adducts with antioxidant flavonoids apigenin, morin and naringin. DNA Cell Biol, 27:433–442.
14.
NagarajanS.R., De CrescenzoG.A., GetmanD.P., LuHF., SikorskiJ.A., WalkerJ.L., McdonaldJ.J., HousemanK.A., KocanG.P., KishoreN., MehtaP.P., Funkes-ShippyC.L., BlystoneL.2003. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. Bioorg Med Chem, 11:4769–4777.
15.
RamirezA.D., WongS.K., MennitiF.S.2003. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur J Pharmacol, 475:29–35.
16.
RajabiM., SignorelliP., GorincioiE., GhidoniR., SantanielloE.2010. Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study. DNA Cell Biol, 29:687–691.
17.
RyuC.K., ChoiK.U., ShimJ.Y., YouH.J., ChoiI.H., ChaeM.J.2003. Synthesis and antifungal activity of 6-arylthio-/6-Arylamino-4,7-dioxobenzothiazoles. Bioorg Med Chem, 11:4003–4008.
18.
Turan-ZitouniG., DemirayakS., OzdemirA., KaplancikliZ.A., YildizM.T.2003. Synthesis of some 2-[(benzazole-2-yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur J Med Chem, 39:267–272.
19.
VichaiV., KirtikaraK.2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc, 1:1112–1116.
20.
WellsG., BradshawT.D., DianaP., SeatonA., ShiD.F., WestwellA.D., StevensM.F.2000. Antitumour benzothiazoles. Part 10. The synthesis and antitumour activity of benzothiazole substituted quinol derivatives. Bioorg Med Chem Lett, 10:513–515.
21.
WestwellA.D.2004. The therapeutic potential of aryl hydrocarbon receptor (AhR) agonists in anticancer drug development. Drugs Future, 29:479–491.
22.
WolterF., SteinJ. 2002. Biological activities of resveratrol and its analogs. Drugs Future, 27:949–959.
